rxstat › Classes › Muscle Relaxants, Centrally Acting Agents
Muscle Relaxants, Centrally Acting Agents: shortage status in Canada
2 of the 5 muscle relaxants, centrally acting agents rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Baclofen (Lioresal Intrathecal) Partial shortage 1 of 17 reported products affected
Tizanidine Partial shortage 1 of 2 reported products affected
Chlorzoxazone Acetaminophen Codeine (Acetazone Forte C8) Discontinued 0 of 1 reported products affected
Cyclobenzaprine No current shortage
Orphenadrine Discontinued 0 of 1 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.